-
Kiss's winning run ends as Argentina hold Australia to draw
-
Argentina threatens to sanction oil projects around Falklands
-
Alcaraz excited to face 'dangerous' Paul for US Open quarter-final berth
-
Gauff into round four at US Open after straight-set win
-
Prince William to represent King Charles III at Norway late King Harald's funeral
-
Bordeaux hammer Racing in Top 14 start as Bielle-Biarrey extends deal
-
Inter and Roma roar back to win thrillers and share top spot
-
Zheng, Potapova pull off upsets to reach US Open last 16
-
Don't stop them now: fans party for Freddie Mercury's 80th birthday
-
Swiatek into US Open fourth round in tight two-setter
-
AFP photographer wins top prize for Madagascar protest coverage
-
Werro wins in Brussels, as Russell and Dos Santos shine
-
Keys: 'I felt like I couldn't play tennis'
-
Kolbe breaks jaw and shoulder injury sidelines Savea
-
Simmonds stars as Pau upset Montpellier
-
US military strikes oil tankers as Iran vows tougher reprisals
-
Inter roar back in five-goal thriller with Napoli
-
Zheng rallies to stun Keys, Anisimova out in US Open third round
-
Haaland keeps Man City perfect in Premier League, blunt Spurs held
-
Bayern held to draw by stubborn Schalke
-
Hamilton worried by Ferrari pace while Antonelli prepares for a fight
-
Lens lose again ahead of Champions League date
-
Vuelta stage 15 shortened due to extreme heat, Mas consolidates lead
-
Olympic champion Zheng storms home to reach US Open last 16
-
Putin meets US envoys for Ukraine war talks
-
Big-spending Spurs must make better attacking decisions, says De Zerbi
-
Modric available for Croatia in Nations League
-
South Africa dominate New Zealand in second half to lead series
-
Potapova upsets 2025 US Open runner-up Anisimova
-
Kiefer Sutherland still in action, but ibuprofen lending helping hand
-
Gasly a 'class act' says Alpine boss after Monza pole
-
'Are we ready?' Oasis film captures band's frosty reunion
-
Athletic Bilbao crush Simeone's flat Atletico
-
Commemoration held for late Bosnian Serb war criminal Ratko Mladic
-
Stay far from battlefield, warns Japanese director in Vietnam War film
-
Haaland keeps new-look Man City perfect in Premier League, blunt Spurs held
-
Tens of thousands of Croatians protest over hazardous waste
-
Alpine's Gasly takes shock pole for Italian Grand Prix
-
Haaland heads unconvincing Man City top of Premier League
-
Nwaneri helps Dortmund to comeback win on Bundesliga debut
-
US envoys in Moscow as Russia and Ukraine vow not to hit capitals during talks
-
US military says destroys Iranian oil tankers after missile attacks
-
Motorsport governing body rejects Alpine boss's claims of bias
-
US envoys in Moscow for Ukraine war negotiations
-
US envoy on West Bank visit says Israel has responsibility for Palestinians
-
Commemoration held for late Serbian war criminal Ratko Mladic
-
Ethiopian Miss World contestant spotlights pain of sister's murder
-
Russell on top ahead of Hamilton in final Italian GP practice
-
'Leader' Raphinha rising to Barca striker challenge
-
Motorsport governing body rejects Alpine boss's claims of impartiality
Atomera Provides Fourth Quarter and Fiscal 2024 Results
LOS GATOS, CA / ACCESS Newswire / February 11, 2025 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the fourth quarter and fiscal year ended December 31, 2024.
Recent Company Highlights
Continued progress toward commercialization at ST Microelectronics
Expanded offerings for gate-all-around products, the foundation technology of the most advanced AI devices
Newly initiated development efforts with two large customers
Management Commentary
"Recent progress with large customers has reinforced the attractiveness of MST to solve some of the most difficult problems faced by semiconductor companies, which is the key to Atomera licensing customers and bringing our technology to production," said Scott Bibaud, President and CEO. "The semiconductor industry is currently in an ideal state to adopt new technology and the performance improvements enabled by MST are compelling to fabs and foundries seeking to gain cost-effective advantages in highly competitive markets."
Financial Results
The Company incurred a net loss of ($4.7) million, or ($0.16) per basic and diluted share in the fourth quarter of 2024, compared to a net loss of ($4.6) million, or ($0.17) per basic and diluted share, for the third quarter of 2024, and a net loss of ($4.6) million, or ($0.18) per basic and diluted share, for the fourth quarter of 2023. Adjusted EBITDA (a non-GAAP financial measure) in the fourth quarter of 2024 was a loss of ($3.9) million compared to an adjusted EBITDA loss of ($3.9) million in the third quarter of 2024 and ($3.7) million in the fourth quarter of 2023.
For fiscal year 2024, revenue was $135,000, compared with $550,000 in fiscal 2023. Net loss was ($18.4) million, or ($0.68) per basic and diluted share for fiscal 2024, compared to ($19.8) million, or ($0.80) per basic and diluted share in fiscal 2023. Adjusted EBITDA for fiscal 2024 was a loss of ($15.4) million compared to an adjusted EBITDA loss of ($16.6) million in fiscal 2023.
The Company had $26.8 million in cash, cash equivalents and short-term investments as of December 31, 2024, compared to $19.5 million as of December 31, 2023.
The total number of shares outstanding was 30.1 million as of December 31, 2024.
Fourth Quarter and Fiscal Year 2024 Results Webinar
Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Tuesday, Feb. 11, 2025
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com
Note about Non-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.
Safe Harbor
This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and knowhow and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 15, 2024. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
-- Financial Tables Follow --
Atomera Incorporated
Balance Sheets
(in thousands, except per share data)
December 31, | December 31, | |||
2024 | 2023 | |||
(Unaudited) | ||||
ASSETS | ||||
Current assets: | ||||
Cash and cash equivalents | $ | 25,778 | $ | 12,591 |
Short-term investments | 995 | 6,940 | ||
Accounts receivable | 6 | - | ||
Unbilled contracts receivable | - | 550 | ||
Interest receivable | 73 | 79 | ||
Prepaid expenses and other current assets | 240 | 244 | ||
Total current assets | 27,092 | 20,404 | ||
Property and equipment, net | 59 | 100 | ||
Long-term prepaid maintenance and supplies | 91 | 91 | ||
Security deposit | 14 | 14 | ||
Operating lease right-of-use asset | 280 | 517 | ||
Financing lease right-of-use-asset | 1,588 | 2,903 | ||
Total assets | $ | 29,124 | $ | 24,029 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||
Current liabilities: | ||||
Accounts payable | $ | 492 | $ | 618 |
Accrued expenses | 239 | 222 | ||
Accrued payroll related expenses | 1,328 | 1,382 | ||
Current operating lease liability | 260 | 264 | ||
Current financing lease liability | 1,253 | 1,328 | ||
Deferred revenue | 4 | - | ||
Total current liabilities | 3,576 | 3,814 | ||
Long-term operating lease liability | 22 | 295 | ||
Long-term financing lease liability | 449 | 1,750 | ||
Total liabilities | 4,047 | 5,859 | ||
Commitments and contingencies | - | - | ||
Stockholders' equity: | ||||
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding at December 31, 2024 and December 31, 2023 | - | - | ||
Common stock: $0.001 par value, authorized 47,500 shares; 30,540 and 26,107 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively; | 31 | 26 | ||
Additional paid-in capital | 246,565 | 221,229 | ||
Other comprehensive income | 1 | - | ||
Accumulated deficit | (221,520 | ) | (203,085 | ) |
Total stockholders' equity | 25,077 | 18,170 | ||
Total liabilities and stockholders' equity | $ | 29,124 | $ | 24,029 |
Atomera Incorporated
Statements of Operations
(in thousands, except per share data)
Three Months Ended | Year Ended | ||||||||||||||
December 31, | September 30, | December 31, | December 31, | ||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | |||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Revenue | $ | 23 | $ | 22 | $ | 550 | $ | 135 | $ | 550 | |||||
Cost of revenue | (13 | ) | (3 | ) | (28 | ) | (123 | ) | (28 | ) | |||||
Gross margin | 10 | 19 | 522 | 12 | 522 | ||||||||||
Operating expenses | |||||||||||||||
Research and development | 2,823 | 2,759 | 2,992 | 11,029 | 12,525 | ||||||||||
General and administrative | 1,811 | 1,812 | 1,875 | 7,266 | 7,075 | ||||||||||
Selling and marketing | 248 | 248 | 452 | 1,053 | 1,599 | ||||||||||
Total operating expenses | 4,882 | 4,819 | 5,319 | 19,348 | 21,199 | ||||||||||
Loss from operations | (4,872 | ) | (4,800 | ) | (4,797 | ) | (19,336 | ) | (20,677 | ) | |||||
Other income (expense) | |||||||||||||||
Interest income | 213 | 176 | 195 | 779 | 723 | ||||||||||
Accretion income | 26 | 59 | 62 | 178 | 283 | ||||||||||
Other income (expense), net | 1 | - | 3 | 73 | 75 | ||||||||||
Interest expense | (25 | ) | (30 | ) | (43 | ) | (129 | ) | (194 | ) | |||||
Total other income (expense), net | 215 | 205 | 217 | 901 | 887 | ||||||||||
Net loss | $ | (4,657 | ) | $ | (4,595 | ) | $ | (4,580 | ) | $ | (18,435 | ) | $ | (19,790 | ) |
Net loss per common share, basic and diluted | $ | (0.16 | ) | $ | (0.17 | ) | $ | (0.18 | ) | $ | (0.68 | ) | $ | (0.80 | ) |
Weighted average number of common shares outstanding, basic and diluted | 28,934 | 27,406 | 25,404 | 27,217 | 24,755 | ||||||||||
Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
(Unaudited)
Three Months Ended | Year Ended | ||||||||||||||
December 31, | September 30, | December 31, | December 31, | ||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | |||||||||||
Net loss (GAAP) | $ | (4,657 | ) | $ | (4,595 | ) | $ | (4,580 | ) | $ | (18,435 | ) | $ | (19,790 | ) |
Depreciation and amortization | 12 | 12 | 17 | 54 | 77 | ||||||||||
Stock-based compensation | 949 | 907 | 1,015 | 3,867 | 4,013 | ||||||||||
Interest income | (213 | ) | (176 | ) | (195 | ) | (779 | ) | (723 | ) | |||||
Accretion income | (26 | ) | (59 | ) | (62 | ) | (178 | ) | (283 | ) | |||||
Other income, net | (1 | ) | - | (3 | ) | (73 | ) | (75 | ) | ||||||
Interest expense | 25 | 30 | 43 | 129 | 194 | ||||||||||
Net loss non-GAAP EBITDA | $ | (3,911 | ) | $ | (3,881 | ) | $ | (3,765 | ) | $ | (15,415 | ) | $ | (16,587 | ) |
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
[email protected]
SOURCE: Atomera, Inc
View the original press release on ACCESS Newswire
R.Lee--AT